These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 8641136)

  • 41. Transcriptional repression mediated by the WT1 Wilms tumor gene product.
    Madden SL; Cook DM; Morris JF; Gashler A; Sukhatme VP; Rauscher FJ
    Science; 1991 Sep; 253(5027):1550-3. PubMed ID: 1654597
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Molecular basis for modulation of biological function by alternate splicing of the Wilms' tumor suppressor protein.
    Laity JH; Dyson HJ; Wright PE
    Proc Natl Acad Sci U S A; 2000 Oct; 97(22):11932-5. PubMed ID: 11050227
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Sequence and structural requirements for high-affinity DNA binding by the WT1 gene product.
    Nakagama H; Heinrich G; Pelletier J; Housman DE
    Mol Cell Biol; 1995 Mar; 15(3):1489-98. PubMed ID: 7862142
    [TBL] [Abstract][Full Text] [Related]  

  • 44. WT1: what has the last decade told us?
    Little M; Holmes G; Walsh P
    Bioessays; 1999 Mar; 21(3):191-202. PubMed ID: 10333728
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Analysis of native WT1 protein from frozen human kidney and Wilms' tumors.
    Iben S; Royer-Pokora B
    Oncogene; 1999 Apr; 18(15):2533-6. PubMed ID: 10229205
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chromosomal localization of seven PAX genes and cloning of a novel family member, PAX-9.
    Stapleton P; Weith A; Urbánek P; Kozmik Z; Busslinger M
    Nat Genet; 1993 Apr; 3(4):292-8. PubMed ID: 7981748
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of the DNA-binding and transcriptional repression activity of the Wilms' tumor gene product, WT1, by cAMP-dependent protein kinase-mediated phosphorylation of Ser-365 and Ser-393 in the zinc finger domain.
    Sakamoto Y; Yoshida M; Semba K; Hunter T
    Oncogene; 1997 Oct; 15(17):2001-12. PubMed ID: 9366517
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [The Wilms' tumor suppressor gene WT1].
    Akiyama T
    Tanpakushitsu Kakusan Koso; 1997 Jul; 42(10 Suppl):1612-7. PubMed ID: 9279088
    [No Abstract]   [Full Text] [Related]  

  • 49. Atypical presentation of Denys-Drash syndrome in a female with a novel Wt1 gene mutation.
    Machin GA
    Birth Defects Orig Artic Ser; 1996; 30(1):269-86. PubMed ID: 9125334
    [No Abstract]   [Full Text] [Related]  

  • 50. Wilms' tumor 1 splice variants have opposite effects on the tumorigenicity of adenovirus-transformed baby-rat kidney cells.
    Menke AL; Riteco N; van Ham RC; de Bruyne C; Rauscher FJ; van der Eb AJ; Jochemsen AG
    Oncogene; 1996 Feb; 12(3):537-46. PubMed ID: 8637710
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
    Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
    Park S; Tomlinson G; Nisen P; Haber DA
    Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An RNA recognition motif in Wilms' tumour protein (WT1) revealed by structural modelling.
    Kennedy D; Ramsdale T; Mattick J; Little M
    Nat Genet; 1996 Mar; 12(3):329-31. PubMed ID: 8589729
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Assignment of the Wilms' tumor (Wt1) gene to rat chromosome bands 3q34-->q35 by in situ hybridization.
    Kindler-Röhrborn A; Zabel S; Koelsch BU
    Cytogenet Cell Genet; 2000; 89(3-4):262-3. PubMed ID: 10965139
    [No Abstract]   [Full Text] [Related]  

  • 55. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1).
    Dehbi M; Ghahremani M; Lechner M; Dressler G; Pelletier J
    Oncogene; 1996 Aug; 13(3):447-53. PubMed ID: 8760285
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Modulation of DNA binding specificity by alternative splicing of the Wilms tumor wt1 gene transcript.
    Bickmore WA; Oghene K; Little MH; Seawright A; van Heyningen V; Hastie ND
    Science; 1992 Jul; 257(5067):235-7. PubMed ID: 1321494
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The speckling domain of the Wilms tumor suppressor WT1 overlaps with the transcriptional repression domain.
    Herzer U; Lutz B; Hartmann K; Englert C
    FEBS Lett; 2001 Apr; 494(1-2):69-73. PubMed ID: 11297737
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Wilms' tumor gene product WT1 arrests macrophage differentiation of HL-60 cells through its zinc-finger domain.
    Deuel TF; Guan LS; Wang ZY
    Biochem Biophys Res Commun; 1999 Jan; 254(1):192-6. PubMed ID: 9920756
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The Wilms' tumor suppressor, WT1, inhibits 12-O-tetradecanoylphorbol-13-acetate activation of the multidrug resistance-1 promoter.
    McCoy C; McGee SB; Cornwell MM
    Cell Growth Differ; 1999 Jun; 10(6):377-86. PubMed ID: 10392899
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.